Drug Shortage Report for APO-LOSARTAN/HCTZ

Last updated on 2018-09-15 History
Report ID 55807
Drug Identification Number 02371235
Brand name APO-LOSARTAN/HCTZ
Common or Proper name LOSARTAN/HCTZ
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-23
Actual start date 2018-07-20
Estimated end date 2018-09-14
Actual end date 2018-09-14
Shortage status Resolved
Updated date 2018-09-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-07-15 English Compare
v2 2018-07-15 French Compare
v3 2018-07-23 English Compare
v4 2018-07-23 French Compare
v5 2018-09-04 English Compare
v6 2018-09-04 French Compare
v7 2018-09-10 English Compare
v8 2018-09-10 French Compare
v9 2018-09-15 English Compare

Showing 1 to 9 of 9